We provide reliable research results through the evaluation of the effectiveness, safety, and cost-effectiveness of healthcare technologies. Our analyses support scientific evidence creation for insurance listings and price negotiations.
We perform cost-effectiveness analyses (CEA) to compare the healthcare costs incurred with the health outcomes achieved by healthcare technologies used in disease prevention and treatment. This process evaluates the clinical and economic impacts, providing essential data for informed decision-making in healthcare policy and practice.
2Local Adaptation of Global Modeling
We specialize in the local adaptation of global healthcare technology models. This involves customizing international models to align with Korean healthcare systems, regulations, and market conditions, ensuring their relevance and effectiveness for local applications. Our expertise enhances decision-making and supports successful market entry strategies.
3Systematic Literature Review and Comprehensive Analysis
We conduct systematic literature reviews to synthesize primary research
We conduct systematic literature reviews to synthesize primary research comprehensively. Utilizing methodologies such as meta-analysis, indirect comparisons, and network meta-analyses, we derive robust and integrated research outcomes. These advanced techniques provide evidence-based conclusions, supporting informed decision-making in healthcare.
4Scientific Evidence from Real-World Clinical Practice
We analyze the outcomes of medical practices and technologies in real-world clinical settings to provide scientific evidence that can enhance the quality of healthcare services. This involves evaluating the effectiveness and safety of treatments and procedures as they are applied in everyday clinical practice, ensuring that our insights contribute to improved patient care and health outcomes.
5Generation of Essential Data for Market Access
We generate critical data to support the market access of pharmaceuticals and healthcare technologies. This includes comprehensive analyses and compilation of key information necessary for regulatory approvals, reimbursement applications, and strategic decision-making. Our evidence-based approach ensures that healthcare technologies are well-prepared for successful market introduction.
6Study on Budget Impact Due to Introduction and Expanded Reimbursement of New Medical Technologies
We conduct research on the budget impact associated with the introduction and expanded reimbursement of new medical technologies. This study aims to understand the economic implications for healthcare systems, providing insights to guide policy decisions and optimize healthcare spending.
7Conducting Institutional and Survey Research
We conduct both institutional and survey research to gather comprehensive data on healthcare practices, technologies, and patient outcomes. These studies offer valuable insights into current trends and support evidence-based decision-making to enhance healthcare delivery and policy.
Strengths
1Expert Team: Our researchers bring extensive experience and specialized expertise in biotechnology, pharmaceuticals, and medical devices, ensuring top-tier research quality.
2Systematic Methodology: We implement scientific, systematic research processes based on standardized manuals, guaranteeing reliable and consistent results.
3Efficient Operations: We leverage the skills and experience of specialized firms through flexible contracts, enhancing our ability to deliver efficient and high-quality outcomes by utilizing professional networks effectively.